{
    "SPADE_N_06292": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_06292",
            "Peptide Name": "Tat-a5",
            "Source": "HIV-Tat (49-57)",
            "Family": "",
            "Gene": "Not found",
            "Sequence": "KAQIRAMECNILGRKKRRQRRR",
            "Sequence Length": 22,
            "UniProt Entry": [
                "http://www.uniprot.org/uniprot/Notavailable"
            ],
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Antimicrobial",
                "Anticancer"
            ],
            "Target Organism": "Tumor cells:HCT 116 (~80% Cytotoxicity at 100 µM)",
            "Hemolytic Activity": "Not available",
            "Cytotoxicity": "Not available",
            "Binding Target": "HIV-Tat",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Free",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C113H211N49O28S2",
            "Mass": 2768.33,
            "PI": 12.0,
            "Net Charge": 9,
            "Hydrophobicity": -1.67,
            "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min",
            "Comments": "Tat-a5 could arrest cancer cells at G2/M phase and make them apoptotic; Tat-a5 would have the potential to inhibit tumor angiogenesis",
            "Literature": [
                {
                    "Title": "A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-59) with cytotoxic and apoptotic effects against human cancer cells",
                    "Pubmed ID": "18656352",
                    "Reference": "Bioorg Med Chem Lett. 2008 Aug 15;18(16)4633-7.",
                    "Author": "Lou H, Gao Y, Zhai M, Qi Y, Chen L, Lv H, Yu J, Li Y.",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=18656352"
                }
            ],
            "Frequent Amino Acids": "RKA",
            "Absent Amino Acids": "DFHOPSTUVWY",
            "Basic Residues": 10,
            "Acidic Residues": 1,
            "Hydrophobic Residues": 6,
            "Polar Residues": 16,
            "Positive Residues": 10,
            "Negative Residues": 1,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06291",
                    "Similarity": 1.0,
                    "Sequence": "KAQIRAMECNIL"
                },
                {
                    "SPADE_ID": "SPADE_N_05069",
                    "Similarity": 1.0,
                    "Sequence": "GRKKRRQRRRPPQ"
                },
                {
                    "SPADE_ID": "SPADE_N_06264",
                    "Similarity": 1.0,
                    "Sequence": "GRKKRRQRRRGGWMWVTNLRTD"
                }
            ]
        }
    }
}